ID

34155

Descripción

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303419

Link

https://clinicaltrials.gov/show/NCT01303419

Palabras clave

  1. 14/1/19 14/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

14 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01303419

Eligibility Breast Cancer NCT01303419

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
woman 21 years of age or older
Descripción

ID.1

Tipo de datos

boolean

the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
Descripción

ID.2

Tipo de datos

boolean

newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
Descripción

ID.3

Tipo de datos

boolean

will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
Descripción

ID.4

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
woman who has already had a lumpectomy for the index lesion.
Descripción

ID.5

Tipo de datos

boolean

woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
Descripción

ID.6

Tipo de datos

boolean

woman who is pregnant or who believe she may be pregnant.
Descripción

ID.7

Tipo de datos

boolean

woman who has breast implant.
Descripción

ID.8

Tipo de datos

boolean

woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Breast Cancer NCT01303419

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
woman 21 years of age or older
boolean
ID.2
Item
the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
boolean
ID.3
Item
newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
boolean
ID.4
Item
will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
woman who has already had a lumpectomy for the index lesion.
boolean
ID.6
Item
woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
boolean
ID.7
Item
woman who is pregnant or who believe she may be pregnant.
boolean
ID.8
Item
woman who has breast implant.
boolean
ID.9
Item
woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial